The estimated Net Worth of Susan B. Washer is at least $848 Thousand dollars as of 18 February 2022. Ms Washer owns over 120,686 units of Applied Genetic Technologies Corp stock worth over $59,659 and over the last 11 years she sold AGTC stock worth over $0. In addition, she makes $788,551 as Pres and CEO & Director at Applied Genetic Technologies Corp.
Sign up
Ms Washer AGTC stock SEC Form 4 insiders trading
Ms has made over 5 trades of the Applied Genetic Technologies Corp stock since 2016, according to the Form 4 filled with the SEC. Most recently she exercised 120,686 units of AGTC stock worth $42,240 on 18 February 2022.
The largest trade she's ever made was exercising 120,686 units of Applied Genetic Technologies Corp stock on 18 February 2022 worth over $42,240. On average, Ms trades about 7,665 units every 111 days since 2014. As of 18 February 2022 she still owns at least 152,971 units of Applied Genetic Technologies Corp stock.
You can see the complete history of Ms Washer stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ms. Susan B. Washer biography
Susan B. Washer is the Pres, CEO & Director at Applied Genetic Technologies Corp.
What is the salary of Ms Washer?
As the Pres and CEO & Director of Applied Genetic Technologies Corp, the total compensation of Ms Washer at Applied Genetic Technologies Corp is $788,551. There are no executives at Applied Genetic Technologies Corp getting paid more.
How old is Ms Washer?
Ms Washer is 60, she's been the Pres and CEO & Director of Applied Genetic Technologies Corp since . There are 1 older and 1 younger executives at Applied Genetic Technologies Corp. The oldest executive at Applied Genetic Technologies Corp is Stephen W. Potter, 65, who is the VP & Chief Bus. Officer.
What's Ms Washer's mailing address?
Susan's mailing address filed with the SEC is C/O APPLIED GENETIC TECHNOLOGIES CORP., 14193 NW 119TH TERRACE, SUITE #10, ALACHUA, FL, 32615.
Insiders trading at Applied Genetic Technologies Corp
Over the last 11 years, insiders at Applied Genetic Technologies Corp have traded over $12,578,298 worth of Applied Genetic Technologies Corp stock and bought 760,946 units worth $8,946,827 . The most active insiders traders include Plc Gsk, Edward Hurwitz, and Ventures, Inc. Med Immune. On average, Applied Genetic Technologies Corp executives and independent directors trade stock every 89 days with the average trade being worth of $18,318. The most recent stock trade was executed by Stephen W Potter on 30 June 2022, trading 8,070 units of AGTC stock currently worth $6,214.
What does Applied Genetic Technologies Corp do?
Applied Genetic Technologies Corp. (AGTC) is a clinical-stage biotechnology company developing genetic therapies for people with rare and debilitating ophthalmic, otologic and central nervous system (CNS) diseases. AGTC is a leader in designing and constructing all critical gene therapy elements and bringing them together to develop customized therapies that address real patient needs. AGTC's most advanced clinical programs leverage its best-in-class technology platform to potentially improve vision for patients with an inherited retinal disease. AGTC has active clinical trials in X-linked retinitis pigmentosa (XLRP) and achromatopsia (ACHM CNGB3 and ACHM CNGA3). Its preclinical programs build on the Company's industry leading AAV manufacturing technology and scientific expertise. AGTC is advancing multiple important pipeline candidates to address substantial unmet clinical need in optogenetics, otology and CNS disorders. In recent years AGTC has entered into strategic partnerships with companies including Otonomy, a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, and Bionic Sight, an innovator in the emerging field of optogenetics and retinal coding.
What does Applied Genetic Technologies Corp's logo look like?
Complete history of Ms Washer stock trades at Applied Genetic Technologies Corp
Applied Genetic Technologies Corp executives and stock owners
Applied Genetic Technologies Corp executives and other stock owners filed with the SEC include:
-
Susan B. Washer,
Pres, CEO & Director -
Stephen W. Potter,
VP & Chief Bus. Officer -
Dr. Abraham Scaria Ph.D.,
Chief Scientific Officer -
Gerald Anthony Reynolds,
Chief Accounting Officer, Principal Accounting Officer & Treasurer -
Jonathan I. Lieber M.B.A.,
Chief Financial Officer -
Dr. Terence R. Flotte M.D.,
Co-Founder -
Dr. Richard Jude Samulski Ph.D.,
Co-Founder -
Dr. William W. Hauswirth,
Co-Founder & Member of Ophthalmology Scientific Advisory Board -
Dr. Barry J. Byrne M.D., Ph.D.,
Co-Founder -
Dr. Nicholas Muzyczka,
Co-Founder -
Edward Hurwitz,
Director -
Michael H. Goldstein,
Chief Medical Officer -
Jeffrey D. Chulay,
V.P. & Chief Medical Officer -
Bruce Peacock,
Director -
Ivana Magovcevic Liebisch,
Director -
Lawrence E Bullock,
Chief Financial Officer -
Arnold L Oronsky,
Director -
Anne Vanlent,
Director -
Scott Koenig,
Director -
Mark S Shearman,
Chief Scientific Officer -
James Rosen,
Director -
Brian Krex,
General Counsel -
Patrick Johan Hendrik Stich...,
-
William A. Sullivan,
Chief Financial Officer -
Abraham Scaria,
Chief Scientific Officer -
Stephen W Potter,
Chief Business Officer -
William Aliski,
Director -
Theresa Heah,
Chief Medical Officer -
Matthew Feinsod,
Exec. VP, Global Strat. & Dev. -
Jill Carroll,
Director -
Daniel L Menichella,
V.P. & Chief Business Officer -
David R. Knop,
Director, Process Development -
Plc Gsk,
10% owner -
Ventures, Inc. Med Immune,
10% owner -
Partners Viii Lp Inter West...,
-
Samuel Wu,
Director -
Partners Viii, L.P.Champsi ...,
-
Susan B. Washer,
President and CEO -
Jonathan I Lieber,
Chief Financial Officer -
Gerald Anthony Reynolds,
Chief Accounting Officer -
Yehia Hashad,
Director -
Hope D Oyley Gay,
General Counsel -
James A. Jr. Robinson,
Director -
Susan Schneider,
Chief Medical Officer